Username
Password
Home
Forgotten Password?
Register Now
Site Map
Advertising
THE DEFINITIVE ARTICLE SEARCH FOR THE GLOBAL PHARMACEUTICALS MARKET
Search:
Advanced Search
This channel:
Outsourced Services
>
Clinical-Trials-Phase-I-to-IV
Most popular article in
Clinical Trials Phase I to IV
Xamiol (R) - LEO Pharma's new drug for the treatment of scalp psoriasis - is approved in Europe
More in detail
Company
:
LEO Pharma
Date Published
:
19/08/2008
Articles in
Clinical Trials Phase I to IV:
Select to view sub-categories of this category
View All
Clinical Research (Field)
Clinical Trials Phase I to IV
Data management
Drug Metabolism
In-patient clinical research
Patient safety monitoring
Pharmacodynamics
Pharmacoeconomics
Pharmacogenetics
Pharmacokinetics
Project management
Statistical analysis
Subject
Contributor
Date Published
Pfizer withdraws application to switch Viagra to non-prescription status in Europe
Pfizer
20/11/2008
Health and care workers to set up new social enterprises
Department of Health
20/11/2008
Intel announces its first home medical device in the United Kingdom to better connect clinicians with patients
Intel Corporation
20/11/2008
Tibotec begins enrollment in Europe for Phase III trial of telaprevir in HCV patients who failed prior treatment
Tibotec Therapeutics
20/11/2008
Second Sight Expands International Clinical Trial For Argus II Retinal Implant
Second Sight® Medical Products, Inc
19/11/2008
Bavarian Nordic Receives USD 25 Million Milestone Payment After Submission Of Important Imvamune(R) Data To The U.S. Health Authorities
Bavarian Nordic A/S
19/11/2008
Patient Temperature Management Systems Enjoying Wider Usage
Frost & Sullivan
19/11/2008
Ginkgo Biloba for prevention of dementia - statement of Dr. Willmar Schwabe Pharmaceutical’s about the ginkgo evaluation of memory (gem) study in the journal of the American Medical Association: gem study leaves questions unanswered
Dr. Willmar Schwabe Pharmaceuticals
19/11/2008
Phil hope launches more 'Pacesetters' to reduce health inequalities
Department of Health
19/11/2008
Shire Plc: Investor Seminar
Shire PLC
18/11/2008
IDM Pharma Receives Recommendation For Approval Of Mifamurtide (Mepact(R), L-MTP-PE) For The Treatment Of Patients With Non-Metastatic, Resectable Osteosarcoma In Europe From The Committee For Medicinal Products For Human Use (CHMP)
IDM Pharma, Inc.
18/11/2008
Government Welcomes Progress In Coordination And Translation Of Health Research For The Benefit Of Patients
Department of Health
18/11/2008
Lilly Selects Icon To Manage Its Clinical Data Management Businessoutside The US
ICON plc
18/11/2008
First Pivotal Trials Begin For Boehringer Ingelheim's Novel Triple Angiokinase Inhibitor Vargatef(TM) (BIBF 1120)
Boehringer Ingelheim
17/11/2008
Exco InTouch Hosts Successful Recruitment and Retention Workshop
Exco InTouch
14/11/2008
BIOTRONIK announces positive clinical trial results at American Heart Association Scientific Sessions
BIOTRONIK GmbH & Co. KG
14/11/2008
Pfizer Launches Global Regenerative Medicine Research Unit
Pfizer
14/11/2008
Will big pharma embrace its orphans?
Frost & Sullivan
14/11/2008
Life expectancy and all age all cause mortality monitoring (overall and health inequalities) - update to include data for 2007
Department of Health
13/11/2008
Corner shops in the North East help customers eat their greens
Department of Health
13/11/2008
First
Previous
1 to 20 of 2676
Next
Last
© CMP information Ltd 2007
Terms and Conditions
Privacy Policy
